Photodynamic therapy using meta-tetrahydroxyphenylchlorin (Foscan®) for the treatment of vulval intraepithelial neoplasia

British Journal of Dermatology

Volumn 151, Issue 5, 2004, Pages 1076-1080

  Campbell, Sandra M ^a   Gould, D J ^a   Salter, L ^a   Clifford, T ^a   Curnow, A ^a  

^a ROYAL CORNWALL HOSPITAL   (United Kingdom)

Author keywords

Foscan ; Meta tetrahydroxyphenylchlorin; Photodynamic therapy; Vulval intraepithelial neoplasia

Indexed keywords

AMINOLEVULINIC ACID; PHOTOSENSITIZING AGENT; TEMOPORFIN;

ADULT; ARTICLE; CANCER CONTROL; CARCINOMA IN SITU; CLINICAL ARTICLE; DIODE LASER; DISEASE SEVERITY; DRUG EFFECT; FEMALE; HUMAN; LIGHT EXPOSURE; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PRIORITY JOURNAL; SQUAMOUS EPITHELIUM; TECHNIQUE; THROMBOCYTE AGGREGATION; VULVA CARCINOMA; VULVA INTRAEPITHELIAL NEOPLASIA; VULVECTOMY;

ADULT; CARCINOMA IN SITU; FEMALE; FOLLOW-UP STUDIES; HUMANS; MESOPORPHYRINS; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PILOT PROJECTS; TREATMENT OUTCOME; VULVAR NEOPLASMS;

EID: 9644289418     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2004.06197.x     Document Type: Article

References (12)

1. Jones RW. Vulval intraepithelial neoplasia: current perspectives. Eur J Gynaecol Oncol 2001; 22: 393-402.
2. Jebakakumar S, Woolley PD, Bhattacharyya MN. Vulval intra-epithelial neoplasia. Int J STD AIDS 1996; 7: 10-13.
3. Henderson BW, Dougherty TJ. How does photodynamic therapy work? Photochem Photobiol 1992; 55: 145-57.
4. Hillemanns P, Untch M, Dannecker C et al. Photodynamic therapy of vulvar intraepithelial neoplasia using 5-aminolevulinic acid, Int J Cancer 2000; 85: 649-53.
5. Kurwa HA, Barlow RJ, Neill S. Single-episode photodynamic therapy and vulval intraepithelial neoplasia type III resistant to conventional therapy. Br J Dermatol 2000; 143: 1040-2.
6. Mene A, Buckley CH. Involvement of the vulval skin appendages by intraepithelial neoplasia. Br J Obstet Gynaecol 1985; 92: 634-8.
7. Andrejevic-Blant S, Hadjur C, Ballini JP et al. Photodynamic therapy of early squamous cell carcinoma with tetra(m-hydroxy-phenyl)chlorin: optimal drug-light interval. Br J Cancer 1997; 76: 1021-8.
8. Cramers P, Ruevekamp M, Oppelaar H et al. Foscan uptake and tissue distribution in relation to photodynamic efficacy. Br J Cancer 2003; 88: 283-90.
9. Bonnett R, White RD, Winfield UJ, Berenbaum MC. Hydroporphyrins of the meso-tetra(hydroxyphenyl)porphyrin series as tumour photosensitizers. Biochem J 1989; 261: 277-80.
10. Ronn AM, Nouri M, Löfgren LA. Human tissue levels and plasma pharmacokinetics of temoporfin (Foscan, mTHPC). Lasers Med Sci 1996; 11:267-72.
11. Jones HJ, Vernon DI, Brown SB. Photodynamic therapy effect of mTHPC (Foscan) in vivo: correlation with pharmacokinetics. Br J Cancer 2003; 89: 398-404.
12. McMahon KS, Wiesman TJ, Moore PH, Fingar VH. Effects of photodynamic therapy using mono-L-aspartyl chlorin on vessel constriction, vessel leakage, and tumor response. Cancer Res 1994; 54: 5374-9.